KL Rahul admits ignoring Virat Kohli's advice, reveals brain behind India's left-hand toss move
Viral video shows German woman’s shock at Delhi’s chaotic traffic, calls experience ‘roller coaster’
What is Right to Disconnect Bill 2025, introduced in Lok Sabha? Can it be passed?
PM Modi issues BIG statement on Indian economy: 'Transformation not merely about...'
Viral video: Foreigner loses cool, climbs onto IndiGo counter amid flight disruptions, watch
HEALTH
Severe malaria occurs when the disease affects the function of vital organs. It is associated with rarer cerebral malaria, which affects the brain and can lead to long-term disability.
Scientists have found that antimalarial drug artesunate, which is derived from herbs used in Chinese medicine, is more effective than quinine at preventing death in patients with severe malaria.
Severe malaria occurs when the disease affects the function of vital organs. It is associated with rarer cerebral malaria, which affects the brain and can lead to long-term disability.
Artesunate was recommended as the preferred treatment for adults with severe malaria by the World Health Organisation (WHO) in 2006, but there was insufficient evidence at the time to recommend a change from the standard treatment of quinine in children.
Cochrane researchers updated the review of artesunate by adding a new large multicentre trial of African children in 2010 to the existing 8 trials.
The review now includes a total of 1664 adults and 5765 children, from a variety of settings across Africa and Asia.
According to the results, taking artesunate reduces the risk of death by 39% in adults and 24% in children compared to quinine.
In adults, deaths caused by severe malaria were reduced from 241 per 1000 with quinine to 147 with artesunate. In children, deaths were reduced from 108 per 1000 with quinine to 83 with artesunate.